The protective proteins in our bodies aren’t just great for fending off infection—they could also fight the effects of ...

Investigational REGN7508 (catalytic domain) and REGN9933 (A2 domain) are being evaluated for their potential to control thrombosis while minimizing bleeding risk in a variety of patient populations ...

Bristol Myers Squibb has turned to the source of Leqembi to further its push into Alzheimer’s disease, paying BioArctic $100 ...

Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McGill University, in ...

Inside the “conundrum” of Botox resistance. Theories behind why one woman is “just not freezing” like she used to and experts ...

It is possible to substantially enhance these antibodies’ therapeutic potential via humanization, effectively reducing ...

Chennai-based Omexa Formulary Pvt Ltd plans to set up a new manufacturing unit for monoclonal antibodies and formulation ...

Arizona State University and Banner Alzheimer's Institute researchers, along with their collaborators, have discovered a ...

Candid Therapeutics, a new San Diego biotech bent on becoming a leader in the emerging T-cell engager space, has unwrapped ...

Researchers have developed and standardized an Open Science platform to characterize research antibodies. This platform, ...

Researchers uncover how the skin autonomously produces antibodies through specialized immune structures, maintaining ...

By Charles Buchanan For people living with autoimmune diseases, their condition can cast a constant shadow over nearly every ...